Biotechnology & Medical Research

Zogenix, Inc Closes Sale of Zohydro ER Business to Pernix

Zogenix, Inc:Says it has closed the sale of its Zohydro ER (hydrocodone bitartrate) business to a wholly owned subsidiary of Pernix Therapeutics Holdings, Inc. for $80 million in cash, about 1.68 million shares of Pernix common stock, plus regulatory and sales milestones of up to $283.5 million.The...

Friday, 24 Apr 2015 12:59pm EDT

StemCells announces pricing of public offering to raise $25 million

StemCells:Prices an underwritten public offering of common stock and warrants with a public offering price of $0.70 for a fixed combination of one share of common stock and a warrant to purchase three-quarters of a share of common stock.Warrants have an exercise price of $0.85 per share, are...

Friday, 24 Apr 2015 09:25am EDT

Pfenex Inc announces pricing of follow-on offering

Pfenex Inc:Says pricing of its follow-on public offering of 6,000,000 shares of its common stock at a price to the public of $15.50 per share.Says of shares being offered, 2,610,000 are being offered by Pfenex and remaining 3,390,000 shares are being offered by existing stockholders.Says company...

Friday, 24 Apr 2015 08:30am EDT

Vanda Pharmaceuticals receives positive CHMP opinion for HETLIOZ (tasimelteon)

Vanda Pharmaceuticals:Says the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending approval of HETLIOZ (tasimelteon) for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) in totally blind adults in the European...

Friday, 24 Apr 2015 07:44am EDT

Mergers & Acquisitions


  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Edison Investment Research
Provider: Edison Investment Research
Provider: Edison Investment Research
Provider: Edison Investment Research
Provider: Edison Investment Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.